A pharmaceutical pricing accord between Britain and the United States will require the National Health Service to spend 25% more on innovative medicines by 2035. Industry sources project this commitment …
© Copyright by HUNGARY JOURNAL (A Digital Media Brand owned by AMAZON MEDIA LLC).